Evidence map›Paper›PMID 24465026›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2014

Longitudinal assessment of the menopausal transition, endogenous sex hormones, and perception of physical functioning: the Study of Women's Health Across the Nation.

Samar R El Khoudary, Candace K McClure, Trang VoPham, Carrie A Karvonen-Gutierrez, Barbara Sternfeld, Jane A Cauley, Naila Khalil, Kim Sutton-Tyrrell

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05346445 nacompletednot on this mapstarted 2021, after this paper: background citation

Citalopram Improves Vasomotor and Urogenital Syndromes in Mexican Patients With Post-menopause

TypeinterventionalSponsorHospital Regional 1o de OctubreRan2021 to 2021Enrolled91ConditionsPostmenopause, Hot FlashesArmsFluoxetine 20 MG, Citalopram 20mg
NCT06432816 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Nano-Pso Therapy Compared to Placebo in the Control of Vasomotor Symptomatology in Early Menopause

TypeinterventionalSponsorDistribuidora Biolife SA de CVRan2024 to 2026Enrolled90ConditionsMenopause, Vasomotor, SyndromeArmsNANO-PSO, PLACEBO
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Geriatric syndromes in women living with HIV.Current opinion in HIV and AIDS · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Aging and changes in adiposity indices: the impact of menopause.Journal of endocrinological investigation · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Physical Activity and Physical Function: Moving and Aging.Obstetrics and gynecology clinics of North America · 2018
    Review
  14. Article
  15. Hysterectomy and perceived physical function in middle-aged Australian women: a 20-year population-based prospective cohort study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Samar R El KhoudaryDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania. elkhoudarys@edc.pitt.edu.
Candace K McClureDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania.
Trang VoPhamDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania.
Carrie A Karvonen-GutierrezDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Barbara SternfeldKaiser Permanente Division of Research, Oakland, California.
Jane A CauleyDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania.
Naila KhalilCenter for Global Health Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Kim Sutton-TyrrellDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania.
University of Pittsburgh · USKaiser Permanente · USUniversity of Michigan–Ann Arbor · US

Funding

WOMENS HEALTH ACROSS THE NATION--COORDINATING CENTERU01AG012553 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BROOKS, MARIA MORI · 1994 to 2019
$37.7M
WOMENS HEALTH ACROSS THE NATION--ENDOCRINE LABU01AG012495 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCCONNELL, DANIEL S · 1994 to 2018
$18.8M
WOMENS HEALTH ACROSS THE NATION--PITTSBURGHU01AG012546 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MATTHEWS, KAREN · 1994 to 2019
$16.2M
WOMENS HEALTH ACROSS THE NATION--UCDAVISU01AG012554 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI GOLD, ELLEN B. · 1994 to 2019
$14.5M
WOMENS HEALTH ACROSS THE NATION--UCLAU01AG012539 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GREENDALE, GAIL A · 1994 to 2018
$13.7M
THE STUDY OF WOMEN'S HEALTH ACROSS THE NATION-MICHIGANU01NR004061 · NINR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HARLOW, SIOBAN D · 1994 to 2018
$12.9M
WOMENS HEALTH ACROSS THE NATION--CHICAGOU01AG012505 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI KRAVITZ, HOWARD M · 1994 to 2019
$11.9M
WOMENS HEALTH ACROSS THE NATION--MASSACHUSETTS GENERAL HU01AG012531 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI FINKELSTEIN, JOEL S · 1994 to 2019
$10.7M
Women's Health Across the Nation-New Jersey SiteU01AG012535 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DERBY, CAROL A. · 1994 to 2019
$9.2M
NIA NIH HHS U01 AG012495NIA NIH HHS U01AG012495NIA NIH HHS U01 AG012505NIA NIH HHS U01AG012505NIA NIH HHS U01 AG012531NIA NIH HHS U01AG012531NIA NIH HHS U01 AG012535NIA NIH HHS U01AG012535NIA NIH HHS U01 AG012539NIA NIH HHS U01AG012539NIA NIH HHS U01 AG012546NIA NIH HHS U01AG012546NIA NIH HHS U01 AG012553NIA NIH HHS U01AG012553NIA NIH HHS U01 AG012554NIA NIH HHS U01AG012554NINR NIH HHS U01 NR004061NINR NIH HHS U01NR004061
6 · The paper itself

Abstract

backgroundTo evaluate the longitudinal associations between menopausal status, related hormonal changes, and level of self-reported physical functioning.

methodsStudy included 2,495 women (age: 45-57 between 2000 and 2001) from the Study of Women's Health Across the Nation. Physical functioning scale of the Medical Outcomes Study Short-Form (SF-36; score 0-100) was categorized as: no limitation (86-100), moderate limitation (51-85), and substantial limitation (0-50). Study variables were collected between 2000 (visit-04) and 2011 (visit-12) at five timepoints. Statistical models were adjusted for age at visit-04, time since visit-04, ethnicity, site, economic status, level and change in body mass index, level and change in physical activity, and presence of comorbid conditions.

resultsIn final models, natural and surgical postmenopausal women had significantly higher odds of functional limitation, compared with premenopausal women. Less reduction in estradiol and testosterone since visit-04 were significantly associated with lower odds of functional limitation, while greater increase in sex hormone-binding globulin was associated with higher odds of functional limitation.

conclusionsOur findings suggest the menopause-related changes in endogenous sex hormones as a possible mechanism of action to explain the greater limitation in physical functioning reported in women at midlife.

Indexed as

Health StatusWomen's HealthActivities of Daily LivingAdultCohort StudiesFemaleGonadal Steroid HormonesHealth Status IndicatorsHumansMenopauseMiddle AgedMotor ActivitySelf ReportGonadal Steroid HormonesEpidemiologyFunctional performanceGeriatric endocrinologyMenopause.Physical function

Identifiers

PMID24465026
PMCPMC4158400
OpenAlexW2114674166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.